• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

父源骨髓输注作为挽救治疗用于母体单倍体相合移植后发生的严重移植物抗宿主病,导致双亲嵌合体。

Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism.

机构信息

Department of Blood and Marrow Transplantation, Apollo Gleneagles Cancer Hospital, 58 Canal Circular Road, Kolkata, 700054, India.

出版信息

Int J Hematol. 2013 Oct;98(4):504-8. doi: 10.1007/s12185-013-1426-5. Epub 2013 Sep 6.

DOI:10.1007/s12185-013-1426-5
PMID:24061772
Abstract

We describe a case of severe GVHD in a 3-year-old child who had received a maternal haploidentical allograft for thalassemia major, which was refractory to several lines of therapy, including weekly infusion of mesenchymal cells. The child was infused paternal marrow graft from which T cells were depleted using Campath 'in the bag' without conditioning. There was significant improvement in gut and liver GVHD over the next few weeks along with persistent mixed biparental chimerism before the child succumbed to CMV pneumonitis. This approach hints at the possibility of using parental TCD marrow to salvage GVHD caused by a graft from the other parent, and raises the possibility of biparental grafting along the same lines as double cord transplantation.

摘要

我们描述了一例严重的移植物抗宿主病(GVHD)患儿,该患儿因重型地中海贫血接受了母亲半相合同种异体移植,该患儿对包括每周输注间充质细胞在内的多种治疗方案均无效。患儿输注了经 Campath 预处理的、去除 T 细胞的父系骨髓,随后数周内,患儿的肠道和肝脏 GVHD 显著改善,且持续存在混合双亲嵌合体,直到患儿死于 CMV 肺炎。这种方法提示了使用父母 TCD 骨髓来挽救由另一方父母供体引起的 GVHD 的可能性,并提出了沿着与双脐带移植相同的思路进行双亲供体移植的可能性。

相似文献

1
Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism.父源骨髓输注作为挽救治疗用于母体单倍体相合移植后发生的严重移植物抗宿主病,导致双亲嵌合体。
Int J Hematol. 2013 Oct;98(4):504-8. doi: 10.1007/s12185-013-1426-5. Epub 2013 Sep 6.
2
[CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].[用于儿童白血病治疗的非T细胞去除单倍体相合骨髓移植中预防移植物抗宿主病的CD25单克隆抗体]
Zhonghua Er Ke Za Zhi. 2004 Apr;42(4):294-8.
3
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.预防性供体白细胞输注对接受非清髓性预处理和异基因骨髓移植治疗的晚期血液系统恶性肿瘤患者混合嵌合体、移植物抗宿主病及抗肿瘤反应的影响
Biol Blood Marrow Transplant. 2003 May;9(5):320-9. doi: 10.1016/s1083-8791(03)00077-6.
4
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.非清髓性预处理疗法及 HLA 配型相合供者骨髓移植后,难治性血液系统恶性肿瘤患者混合嵌合体的诱导及抗肿瘤反应的实现。
Biol Blood Marrow Transplant. 2000;6(3A):309-20. doi: 10.1016/s1083-8791(00)70056-5.
5
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.对非遗传母体抗原的耐受性对来自父母或 HLA 单倍型相同同胞的骨髓移植后移植物抗宿主病发生情况的影响。
Blood. 2002 Mar 1;99(5):1572-7. doi: 10.1182/blood.v99.5.1572.
6
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.T细胞清除联合供体白细胞输注的挽救性免疫疗法作为治疗接受人类白细胞抗原(HLA)相合同胞骨髓移植的慢性期慢性粒细胞白血病患者的一种策略。
Blood. 1999 Jul 15;94(2):434-41.
7
Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.间充质干细胞增强骨髓移植后大鼠后肢同种异体移植物混合嵌合体的诱导和耐受。
J Surg Res. 2010 May 15;160(2):315-24. doi: 10.1016/j.jss.2008.09.027. Epub 2008 Nov 4.
8
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.混合嵌合体对再生障碍性贫血或慢性粒细胞白血病患者接受 HLA 全相合骨髓移植后移植物抗宿主病、疾病复发及生存的影响。
Bone Marrow Transplant. 1996 Oct;18(4):767-76.
9
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.低剂量全身照射、氟达拉滨和抗胸腺细胞球蛋白预处理用于非清髓性异基因移植。
Biol Blood Marrow Transplant. 2003 Jul;9(7):453-9. doi: 10.1016/s1083-8791(03)00139-3.
10
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.针对自体干细胞移植后复发患者的异基因细胞疗法。
Biol Blood Marrow Transplant. 2001;7(4):230-8. doi: 10.1053/bbmt.2001.v7.pm11349810.

引用本文的文献

1
Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.单倍体相合外周血干细胞移植联合移植后环磷酰胺治疗后的噬血细胞综合征
Int J Hematol. 2016 Feb;103(2):234-42. doi: 10.1007/s12185-015-1905-y. Epub 2015 Nov 30.

本文引用的文献

1
Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.双 HLA 半相合造血干细胞移植可使来自两位供者的骨髓成功植入,而无移植物抗宿主病或移植物抗白血病效应。
Biol Blood Marrow Transplant. 2012 Dec;18(12):1808-18. doi: 10.1016/j.bbmt.2012.09.012. Epub 2012 Oct 16.
2
Steroid-Refractory Acute GVHD: Predictors and Outcomes.类固醇难治性急性移植物抗宿主病:预测因素与结局
Adv Hematol. 2011;2011:601953. doi: 10.1155/2011/601953. Epub 2011 Nov 3.
3
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
异基因造血干细胞移植治疗 HLA mismatched 造血干细胞移植后重症、难治性急性移植物抗宿主病
Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27.
4
Treatment of graft-versus-host-disease with mesenchymal stromal cells.间充质基质细胞治疗移植物抗宿主病。
Cytotherapy. 2011 Mar;13(3):262-8. doi: 10.3109/14653249.2010.549688. Epub 2011 Jan 13.
5
Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD.
Bone Marrow Transplant. 2010 Nov;45(11):1658-60. doi: 10.1038/bmt.2010.17. Epub 2010 Feb 22.
6
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.脐带血移植后的复发风险:2单位移植受者的移植物抗白血病效应增强
Blood. 2009 Nov 5;114(19):4293-9. doi: 10.1182/blood-2009-05-220525. Epub 2009 Aug 25.
7
Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.通过第三方异基因供体进行骨髓移植实现已确立的移植物抗宿主病的缓解。
Exp Hematol. 2008 Sep;36(9):1216-25. doi: 10.1016/j.exphem.2008.03.018. Epub 2008 Jul 2.
8
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.用泼尼松龙治疗急性移植物抗宿主病:+5天有反应者有显著生存优势,而接受抗胸腺细胞球蛋白治疗的无反应者无优势。
Blood. 2006 May 15;107(10):4177-81. doi: 10.1182/blood-2005-12-4851. Epub 2006 Jan 31.
9
Autologous/syngeneic stem cell transplantation to treat refractory GvHD.
Bone Marrow Transplant. 2004 Dec;34(11):995-8. doi: 10.1038/sj.bmt.1704658.
10
T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival.
Br J Haematol. 2003 Apr;121(1):109-18. doi: 10.1046/j.1365-2141.2003.04228.x.